Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDInnate Pharma S.A. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.33 | -$0.33 | -$0.33 |
Innate Pharma S.A. Earnings Date And Information
Innate Pharma S.A. last posted its earnings results on Tuesday, March 10th, 2020. The company reported $-0.58679 earnings per share for the quarter, missing analysts' consensus estimates of $-0.18 by $0.40679. The company had revenue of 6.17 M for the quarter and had revenue of 51.90 M for the year. Innate Pharma S.A. has generated $0 earnings per share over the last year ($-0.0941 diluted earnings per share) and currently has a price-to-earnings ratio of -4.63. Innate Pharma S.A. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based on prior year's report dates.
Innate Pharma S.A. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/12/2024 | Q2 2024 | -$0.15 | $10.30 M | $6.17 M | ||
| 03/30/2024 | Q1 2024 | -$0.15 | $6.17 M | |||
| 12/29/2023 | Q4 2023 | -$0.06 | $10.72 M | |||
| 09/29/2023 | Q3 2023 | -$0.06 | $10.72 M | |||
| 06/29/2023 | Q2 2023 | $0.02 | $35.34 M | |||
| 03/30/2023 | Q1 2023 | $0.01 | $20.10 M | |||
| 12/30/2022 | Q4 2022 | -$0.80 | $8.31 M | |||
| 09/29/2022 | Q3 2022 | -$0.41 | $6.04 M | |||
| 06/29/2022 | Q2 2022 | $0.08 | $41.27 M | |||
| 03/30/2022 | Q1 2022 | $0.04 | $22.79 M | |||
| 12/30/2021 | Q4 2021 | -$0.37 | $2.79 M | |||
| 09/29/2021 | Q3 2021 | -$0.17 | $5.70 M | |||
| 06/29/2021 | Q2 2021 | -$0.30 | $9.32 M | |||
| 03/30/2021 | Q1 2021 | -$0.11 | $6.66 M | |||
| 12/30/2020 | Q4 2020 | -$0.68 | $26.99 M | |||
| 09/29/2020 | Q3 2020 | -$0.34 | $16.85 M | |||
| 06/29/2020 | Q2 2020 | -$0.13 | $29.84 M | |||
| 03/30/2020 | Q1 2020 | -$0.07 | $18.37 M | |||
| 12/30/2019 | Q4 2019 | -$0.52 | $17.39 M | |||
| 09/29/2019 | Q3 2019 | -$0.24 | $13.33 M |
Innate Pharma S.A. Earnings: FAQ's
When is Innate Pharma S.A.'s earnings date?
Innate Pharma S.A. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based off last year's report dates.
How can I listen to Innate Pharma S.A.'s earnings conference
call?
The conference call for Innate Pharma S.A.'s latest earnings report can be listened to online.
How can I read Innate Pharma S.A.'s conference call transcript?
The conference call transcript for Innate Pharma S.A.'s latest earnings report can be read online.
How much revenue does Innate Pharma S.A. generate each year?
Innate Pharma S.A. (:IPHA) has a recorded annual revenue of $51.90 M.
How much profit does Innate Pharma S.A. generate each year?
Innate Pharma S.A. (:IPHA) has a recorded net income of $51.90 M. Innate Pharma S.A. has generated $-0.0941 earnings per share over the last four quarters.
What is Innate Pharma S.A.'s price-to-earnings ratio?
Innate Pharma S.A. (:IPHA) has a price-to-earnings ratio of -4.63 and price/earnings-to-growth ratio is 0.06.